CNP 061

Drug Profile

CNP 061

Alternative Names: CNP-061; GT-061

Latest Information Update: 29 Jun 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cita NeuroPharmaceuticals
  • Class Hypnosedatives; Nootropics; Sleep disorder therapies
  • Mechanism of Action GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Insomnia

Most Recent Events

  • 21 Jun 2005 Discontinued - Preclinical for Insomnia in Canada (unspecified route)
  • 02 Jun 2005 GB Therapeutics is now called Cita NeuroPharmaceuticals
  • 28 Jun 2004 This compound is not in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top